Virgo wins major new diabetes launch account
February 26, 2009Medical Communications Virgo
London-based healthcare PR specialist Virgo Health has won the UK account for new diabetes drug Onglyza. Due to be launched …
Europe approves Lilly’s Plavix rival
February 25, 2009Research and Development, Sales and Marketing Daiichi, Effient, lilly
Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …
Genentech urges shareholders to reject Roche bid
February 24, 2009Sales and Marketing Genentech, Roche
The battle for the future of Genentech has heated up after the company's board asked its shareholders to reject Roche's …
NovaBiotics: a rising star for 2009
February 24, 2009Research and Development NovaBiotics
Biologics company NovaBiotics has been dubbed a Rising Star for 2009 by the Scottish arm of the BioIndustry Association. The …
R&D tax credits among anticipated changes for US healthcare
February 24, 2009Research and Development US, healthcare
With the election of Barack Obama, widespread changes are anticipated for US healthcare and ultimately for the pharmaceutical industry. Although …
Bringing global trials teams together
February 23, 2009Research and Development clinical trials, global
The world is getting bigger and smaller at the same time. When the internet began to really catch on about …
Roche rejoins ABPI after six-month suspension
February 23, 2009Sales and Marketing Code of Practice, Roche
Roche has been allowed to rejoin the ranks of the ABPI, after its six-month suspension for bringing discredit on the …
Shire acquires ADHD presence in Europe
February 23, 2009Sales and Marketing ADHD, Shire
Shire has bought the global rights for two established treatments for Attention Deficit Hyperactivity Disorder from UCB. The acquisition gives …
CV Therapeutics rejects Astellas takeover bid
February 23, 2009Sales and Marketing Astellas, CV Therapeutics
Biotech company CV Therapeutics has rejected a second take-over offer from Astellas, saying the Japanese group failed to recognise its …
The Pharmafocus interview: Simon Jose
February 20, 2009Sales and Marketing GlaxoSmithKline, Simon Jose, UK, partnerships, pricing
Like all his contemporaries in the UK, Simon Jose, GlaxoSmithKline’s head of UK operations has to focus on some of …
Raptiva suspended in Europe over safety concerns
February 20, 2009Research and Development, Sales and Marketing Europe, Rapitva
Psoriasis treatment Raptiva is to be suspended from use in the European Union because of concerns about rare but serious …
Servier claims victory over NICE in osteoporosis
February 19, 2009Research and Development, Sales and Marketing NICE, Servier
Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …
GSK’s diabetes candidate enters phase III
February 19, 2009Research and Development GSK, diabetes
A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …
Anger over private firm’s role in prescribing controls
February 19, 2009NHS
Pharmacy and GP representatives have attacked plans for a private company to oversee primary care prescribing costs.Private provider Assura is …
Sanofi-Aventis joins YouTube revolution
February 18, 2009Sales and Marketing Sanofi-Aventis, diabetes
Sanofi-Aventis has launched its first YouTube channel, aimed at diabetes sufferers in the US.Reached by typing the keyword goinsulin into …
Genzyme says new plant approval is imminent
February 18, 2009Research and Development, Sales and Marketing Genzyme
Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …
Novartis and charity team up on AMD campaign
February 18, 2009Medical Communications, Sales and Marketing AMD, ophthalmology
Novartis has teamed up with blindness charity the RNIB on a new campaign to promote awareness of age-related macular degeneration …
Lilly to boost biotech stake in NeuroSearch deal
February 17, 2009Research and Development Denmark, Europe, NeuroSearch
Lilly has signed a new deal with Danish biotech company NeuroSearch and increased its presence further in the biologics sector.The …
Pharma needs fresh ideas from outside industry, says Barker
February 17, 2009Research and Development, Sales and Marketing ABPI, strategy
Pharma must re-invent itself and inject new ideas into its business model by hiring talented people from outside the sector, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
